3 days ago
2
0
Posted On: November 2nd 2026, 02:15 pm
Big peptide news last week, and our team dug into the actual HHS policy (not just the headlines).
The short version: on Oct 28, HHS said it won't take enforcement action against licensed 503A pharmacies and physicians compounding six specific peptides, as long as strict conditions are met. That's different from FDA approval, and it's an interim policy while formal rules are written.
Sources: HHS policy + Federal Register, NPR, NBC News.
Educational only, not medical advice.
#peptides #compounding #503A #pharmacy #FDA #HHS #patientsafety #peptidenews #PeptideMatch
The short version: on Oct 28, HHS said it won't take enforcement action against licensed 503A pharmacies and physicians compounding six specific peptides, as long as strict conditions are met. That's different from FDA approval, and it's an interim policy while formal rules are written.
Sources: HHS policy + Federal Register, NPR, NBC News.
Educational only, not medical advice.
#peptides #compounding #503A #pharmacy #FDA #HHS #patientsafety #peptidenews #PeptideMatch
More posts
